Statin use in patients with asthma - a nationwide population-based study

European Journal of Clinical Investigation

Volumn 41, Issue 5, 2011, Pages 507-512

  Huang, Chin Chou ^a,b   Chan, Wan Leong ^a   Chen, Yu Chun ^a,c   Chen, Tzeng Ji ^a,b   Chou, Kun Ta ^a   Lin, Shing Jong ^a,b   Chen, Jaw Wen ^a,b   Leu, Hsin Bang ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Asthma; Hospitalization; National health insurance; Statin

Indexed keywords

ANTIASTHMATIC AGENT; ATORVASTATIN; CORTICOSTEROID; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; ARTICLE; ASTHMA; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG USE; FEMALE; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL;

ASTHMA; CASE-CONTROL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; TAIWAN;

EID: 79953746639     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02434.x     Document Type: Article

References (42)

1. Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-78.
2. Hsieh KH, Shen JJ. Prevalence of children asthma in Taipei, Taiwan, and other Asian Pacific countries. J Asthma 1988;25:73-82.
3. Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368: 733-43.
4. de Marco R, Cazzoletti L, Cerveri I, Corsico A, Bugiani M, Accordini S et al. Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma Int Arch Allergy Immunol 2005;138:225-34.
5. Pedersen TR. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
6. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999;282:2340-6.
7. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. West of Scotland Coronary Prevention Group. N Engl J Med 1995;333:1301-7.
8. Briel M, Studer M, Glass TR, Bucher HC. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2004;117: 596-606.
9. Amarenco P, Labreuche J, Lavallée P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-9.
10. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005;352:29-38.
11. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005;352:20-8.
12. Alexeeff SE, Litonjua AA, Sparrow D, Vokonas PS, Schwartz J. Statin use reduces decline in lung function: VA Normative Aging Study. Am J Respir Crit Care Med 2007;176:742-7.
13. Hothersall E, McSharry C, Thomson NC. Potential therapeutic role for statins in respiratory disease. Thorax 2006;61:729-34.
14. Imamura M, Okunishi K, Ohtsu H, Nakagome K, Harada H, Tanaka R et al. Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung. Thorax 2009;64:44-9.
15. Zeki AA, Franzi L, Last J, Kenyon NJ. Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. Am J Respir Crit Care Med 2009;180:731-40.
16. Ostroukhova M, Kouides RW, Friedman E. The effect of statin therapy on allergic patients with asthma. Ann Allergy Asthma Immunol 2009;103:463-8.
17. Hothersall EJ, Chaudhuri R, McSharry C, Donnelly I, Lafferty J, McMahon AD et al. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax 2008;63:1070-5.
18. Menzies D, Nair A, Meldrum KT, Fleming D, Barnes M, Lipworth BJ. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol 2007;119:328-35.
19. Bureau of National Health Insurance. 2001 National Health Insurance Annual Statistical Report. Taipei, Taiwan: Bureau of National Health Insurance; 2002.
20. WHO Collaborating Center for Drug Statistics Methodology. ATC Index with DDDs 2003. Oslo: WHO; 2003.
21. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425-30.
22. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279: 1477-82.
23. Almuti K, Rimawi R, Spevack D, Ostfeld RJ. Effects of statins beyond lipid-lowering: potential for clinical benefits. Int J Cardiol 2006;109:7-15.
24. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89-118.
25. Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat Rev Cancer 2005;5:930-42.
26. Aronson D, Roterman I, Yigla M, Kerner A, Avizohar O, Sella R et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med 2006;174:626-32.
27. Fogarty AW, Jones S, Britton JR, Lewis SA, McKeever TM. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 2007;62:515-20.
28. Shaaban R, Kony S, Driss F, Leynaert B, Soussan D, Pin I et al. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir Med 2006;100:2112-20.
29. Fessler MB, Young SK, Jeyaseelan S, Lieber JG, Arndt PG, Nick JA et al. A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense. Am J Respir Crit Care Med 2005;171:606-15.
30. McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov O, Ford I et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 2004;363:2015-21.
31. Katznelson S, Wang XM, Chia D, Ozawa M, Zhong HP, Hirata M et al. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro. J Heart Lung Transplant 1998;17:335-40.
32. Takahashi HK, Mori S, Iwagaki H, Yoshino T, Tanaka N, Weitz-Schmidt G et al. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes. J Leukoc Biol 2005;77:400-7.
33. Watkins AD, Hatfield CA, Fidler SF, Winterrowd GE, Brashler JR, Sun FF et al. Phenotypic analysis of airway eosinophils and lymphocytes in a Th-2-driven murine model of pulmonary inflammation. Am J Respir Cell Mol Biol 1996;15:20-34.
34. Morimoto K, Janssen WJ, Fessler MB, Xiao YQ, McPhillips KA, Borges VM et al. Statins enhance clearance of apoptotic cells through modulation of Rho-GTPases. Proc Am Thorac Soc 2006;3:516-7.
35. Huang CC, Chen YC, Leu HB, Chen TJ, Lin SJ, Chan WL et al. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention. Am J Cardiol 2010;105:1705-9.
36. Kung YY, Chen YC, Hwang SJ, Chen TJ, Chen FP. The prescriptions frequencies and patterns of Chinese herbal medicine for allergic rhinitis in Taiwan. Allergy 2006;61:1316-8.
37. Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J et al. Statin adherence and risk of accidents: a cautionary tale. Circulation 2009;119:2051-7.
38. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population-based prospective cohort study. BMJ 2006;333:999.
39. Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest 1999;116:603-13.
40. Parameswaran K, Hildreth AJ, Chadha D, Keaney NP, Taylor IK, Bansal SK. Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey. Respir Med 1998;92:573-7.
41. Hartert TV, Togias A, Mellen BG, Mitchel EF, Snowden MS, Griffin MR. Underutilization of controller and rescue medications among older adults with asthma requiring hospital care. J Am Geriatr Soc 2000;48:651-7.
42. Chen CY, Chiu HF, Yeh MK, Yang CY. Use of anti-asthmatic medications in elderly Taiwanese patients. Kaohsiung J Med Sci 2003;19:305-12.